T2 Biosystems, Inc. (TTOO)
0.01
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
T2 Biosystems Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -106.6% |
| June 30, 2024 | -37.96% |
| March 31, 2024 | -103.9% |
| December 31, 2023 | -57.71% |
| September 30, 2023 | -173.4% |
| June 30, 2023 | -153.0% |
| March 31, 2023 | -92.25% |
| December 31, 2022 | 31.28% |
| September 30, 2022 | -65.49% |
| June 30, 2022 | 14.04% |
| March 31, 2022 | 14.22% |
| December 31, 2021 | 23.18% |
| September 30, 2021 | 36.46% |
| June 30, 2021 | 27.83% |
| March 31, 2021 | 16.76% |
| December 31, 2020 | 4.01% |
| September 30, 2020 | -30.28% |
| June 30, 2020 | 10.15% |
| March 31, 2020 | -58.82% |
| December 31, 2019 | -17.63% |
| September 30, 2019 | -135.2% |
| June 30, 2019 | -167.2% |
| March 31, 2019 | -145.8% |
| Date | Value |
|---|---|
| December 31, 2018 | -214.2% |
| September 30, 2018 | -23.36% |
| June 30, 2018 | 12.03% |
| March 31, 2018 | -41.63% |
| December 31, 2017 | -123.1% |
| September 30, 2017 | -90.07% |
| June 30, 2017 | -108.1% |
| March 31, 2017 | -72.90% |
| December 31, 2016 | -138.6% |
| September 30, 2016 | -74.72% |
| June 30, 2016 | -79.90% |
| March 31, 2016 | 6.39% |
| December 31, 2015 | 9.99% |
| September 30, 2015 | -15.16% |
| June 30, 2015 | 38.48% |
| March 31, 2015 | -36.17% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.00% |
| September 30, 2013 | -69.23% |
| June 30, 2013 | -21.67% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ABVC BioPharma, Inc. | -- |
| Anika Therapeutics, Inc. | 61.57% |
| Perspective Therapeutics, Inc. | -5.86K% |
| MiMedx Group, Inc. | 79.33% |
| Abbott Laboratories | 50.36% |